| Trade Date | Insider | Title | Buy or Sell | Quantity | Security Type | Price | Proceeds | Transaction Conviction | Position Quantity | Position Value | Positon Conviction | SEC Link | Nature of Ownership | 2021-02-28 | Martin B Shirley | President - DIS | Buy | 276 | Common Stock | $0.00 | $0.00 | - | 6,546 | $0.00 | 13.75 [Average] | Form 4 | - | 2021-02-28 | Martin B Shirley | President - DIS | Sell | 82 | Common Stock | $3.38 | $277.16 | 0.17 [ Low ] | 6,464 | $21,848.32 | 13.58 [Average] | Form 4 | - | 2021-02-28 | Martin B Shirley | President - DIS | Buy | 350 | Common Stock | $0.00 | $0.00 | - | 6,814 | $0.00 | 14.32 [Average] | Form 4 | - | 2021-02-28 | Martin B Shirley | President - DIS | Sell | 104 | Common Stock | $3.38 | $351.52 | 0.22 [ Low ] | 6,710 | $22,679.80 | 14.10 [Average] | Form 4 | - | 2021-02-28 | Matthew G. Molchan | Pres. & CEO Digirad Health | Buy | 1,049 | Common Stock | $0.00 | $0.00 | - | 28,784 | $0.00 | 60.47 [High] | Form 4 | - | 2021-02-28 | Matthew G. Molchan | Pres. & CEO Digirad Health | Sell | 372 | Common Stock | $3.38 | $1,257.36 | 0.78 [ High ] | 28,412 | $96,032.56 | 59.69 [High] | Form 4 | - | 2021-02-28 | Matthew G. Molchan | Pres. & CEO Digirad Health | Buy | 1,327 | Common Stock | $0.00 | $0.00 | - | 29,739 | $0.00 | 62.48 [High] | Form 4 | - | 2021-02-28 | Matthew G. Molchan | Pres. & CEO Digirad Health | Sell | 470 | Common Stock | $3.38 | $1,588.60 | 0.99 [ High ] | 29,269 | $98,929.22 | 61.49 [High] | Form 4 | - | 2021-05-15 | Martin B Shirley | President - DIS | Buy | 4,459 | Common Stock | $0.00 | $0.00 | - | 11,169 | $0.00 | 22.69 [High] | Form 4 | - | 2021-05-15 | Martin B Shirley | President - DIS | Sell | 1,046 | Common Stock | $2.59 | $2,709.14 | 2.13 [ High ] | 10,123 | $26,218.57 | 20.57 [High] | Form 4 | - | 2021-05-15 | Matthew G. Molchan | Pres. & CEO Digirad Health | Buy | 7,120 | Common Stock | $0.00 | $0.00 | - | 36,389 | $0.00 | 73.93 [Very High] | Form 4 | - | 2021-05-15 | Matthew G. Molchan | Pres. & CEO Digirad Health | Sell | 2,144 | Common Stock | $2.59 | $5,552.96 | 4.36 [ Very High ] | 34,245 | $88,694.55 | 69.58 [Very High] | Form 4 | - | 2021-05-15 | David J. Noble | COO; CFO | Buy | 9,146 | Common Stock | $0.00 | $0.00 | - | 59,624 | $0.00 | 121.14 [Very High] | Form 4 | - | 2021-06-07 | Jeffrey E. Eberwein | Executive Chairman | Buy | 22,000 | Common Stock | $2.25 | -$49,500.00 | 43.84 [ Very High ] | 179,213 | $403,229.25 | 357.14 [Very High] | Form 4 | - | 2021-06-15 | Mitchell I Quain | - | Buy | 11,000 | Common Stock | $2.25 | -$24,750.00 | 21.92 [ Very High ] | 39,047 | $87,855.75 | 77.81 [Very High] | Form 4 | By Mitchell Quain Revoc. Liv. Trust U/A 1/25/18 | 2021-08-07 | Mitchell I Quain | - | Buy | 12,000 | Common Stock | $0.00 | $0.00 | - | 28,681 | $0.00 | 57.16 [High] | Form 4 | - | 2021-08-07 | John W. Sayward | - | Buy | 12,000 | Common Stock | $0.00 | $0.00 | - | 32,699 | $0.00 | 65.16 [High] | Form 4 | - | 2021-08-07 | Jeffrey E. Eberwein | Executive Chairman | Buy | 12,000 | Common Stock | $0.00 | $0.00 | - | 191,213 | $0.00 | 381.05 [Very High] | Form 4 | - | 2021-08-07 | Michael A. Cunnion | - | Buy | 12,000 | Common Stock | $0.00 | $0.00 | - | 28,297 | $0.00 | 56.39 [High] | Form 4 | - | 2021-08-17 | Mitchell I Quain | - | Buy | 3,358 | Common Stock | $0.00 | $0.00 | - | 32,039 | $0.00 | 63.14 [High] | Form 4 | - | 2021-08-17 | John W. Sayward | - | Buy | 3,358 | Common Stock | $0.00 | $0.00 | - | 36,057 | $0.00 | 71.06 [Very High] | Form 4 | - | 2021-08-17 | Jeffrey E. Eberwein | Executive Chairman | Buy | 3,358 | Common Stock | $0.00 | $0.00 | - | 194,571 | $0.00 | 383.47 [Very High] | Form 4 | - | 2021-08-17 | Michael A. Cunnion | - | Buy | 3,358 | Common Stock | $0.00 | $0.00 | - | 31,655 | $0.00 | 62.39 [High] | Form 4 | - | 2021-08-20 | Jeffrey E. Eberwein | Executive Chairman | Sell | 1,058 | 10% Series A Cumulative Perpetual Preferred Stock | $10.49 | $11,098.42 | 2.09 [ High ] | 658,978 | $6,912,679.22 | 1,298.73 [Very High] | Form 4 | - | 2021-11-19 | Mitchell I Quain | - | Buy | 3,719 | Common Stock | $0.00 | $0.00 | - | 35,758 | $0.00 | 69.83 [High] | Form 4 | - | 2021-11-19 | John W. Sayward | - | Buy | 3,719 | Common Stock | $0.00 | $0.00 | - | 39,776 | $0.00 | 77.67 [Very High] | Form 4 | - | 2021-11-19 | Jeffrey E. Eberwein | Executive Chairman | Buy | 3,719 | Common Stock | $0.00 | $0.00 | - | 198,290 | $0.00 | 387.21 [Very High] | Form 4 | - | 2021-11-19 | Michael A. Cunnion | - | Buy | 3,719 | Common Stock | $0.00 | $0.00 | - | 35,374 | $0.00 | 69.08 [High] | Form 4 | - | 2021-11-22 | Jeffrey E. Eberwein | Executive Chairman | Sell | 5,916 | 10% Series A Cumulative Perpetual Preferred Stock | $10.51 | $62,177.16 | 11.55 [ Very High ] | 1,303,062 | $13,695,181.62 | 2,544.55 [Very High] | Form 4 | - | 2021-11-23 | Jeffrey E. Eberwein | Executive Chairman | Sell | 12,010 | 10% Series A Cumulative Perpetual Preferred Stock | $10.52 | $126,345.20 | 23.45 [ Very High ] | 1,291,052 | $13,581,867.04 | 2,521.09 [Very High] | Form 4 | - | 2021-11-24 | Jeffrey E. Eberwein | Executive Chairman | Sell | 1,074 | 10% Series A Cumulative Perpetual Preferred Stock | $10.57 | $11,352.18 | 2.10 [ High ] | 1,289,978 | $13,635,067.46 | 2,519.00 [Very High] | Form 4 | - |
|---|
